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This article proposes the notion of ‘evidence-based activism’ to capture patients’ and 
health activists’ groups’ focus on knowledge production and knowledge mobilisation in the 
governance of health issues. It introduces empirical data and analysis on groups active in four 
countries (France, Ireland, Portugal, and the UK), and in four condition areas (rare diseases, 
Alzheimer’s disease, ADHD – Attention Deficit Hyperactivity Disorder, and childbirth). It 
shows how these groups engage with, and articulate a variety of credentialed knowledge and 
‘experiential knowledge’ with a view to explore concerned people’s situations, to make 
themselves part and parcel of the networks of expertise on their conditions in their national 
contexts, and to elaborate evidence on the issues they deem important to address both at an 
individual and a collective level. 
This article argues that in contrast to health movements which contest institutions from 
the outside, patients’ and activists’ groups which embrace ‘evidence-based activism’ work 
‘from within’ to imagine new epistemic and political appraisal of their causes and conditions. 
‘Evidence-based activism’ entails a collective inquiry associating patients/activists and 
specialists/professionals in the conjoint fabrics of scientific statements and political claims. 
From a conceptual standpoint, ‘evidence-based activism’ sheds light on the on-going co-
production of matters of fact and matters of concern in contemporary technological 
democracies. 
Keywords 
Evidence-based activism, patients’ and health activists’ groups, expertise, healthcare 
policies, collective inquiry, technological democracies. 
Introduction 
Over the last two decades, social scientists have renewed their interest in patients’ 
organisations, users’ and activists’ groups in the domain of health and medicine. This is due 
to interlinked transformations that significantly affect the sector of health and medicine: 1) the 
growing reliance on EBM for defining and managing care protocols; 2) the proliferation of 
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diagnostic and therapeutic targets, and the complex regulation of the markets of drugs and 
medical products; 3) the challenges to the power of the medical profession and the 
strengthening of mechanisms of accountability; 4) the increased involvement of patients’ 
groups in biomedical research; and 5) the emergence of new legislative frameworks that 
recognise patients and users as stakeholders in health policies in Western countries. The 
complex interactions that patients’ organisations, users’ and activists’ groups build with these 
processes have attracted the attention of social scientists. Combining perspectives from new 
social movement studies, science and technology studies, political sciences, sociology and 
anthropology of biomedicine, and organisation studies, special issues of journals (Brown & 
Zavetovki 2004; Landzelius 2006), as well as edited books (Löfgren et al. 2011; Hoffman et 
al. 2011), have examined issues related to the politics of illness, the shaping of collective 
identities, the relationship between experts and lay people, the democratisation of health, and 
the articulation between science, medicine and the market. Contributing authors of these 
publications have also engaged in reflection on the analytical concepts and frameworks that 
best capture the role of patients’ organisations, users’ and activists’ groups in these compound 
processes. 
This special issue takes this body of research a step further to put forward the concept of 
‘evidence-based activism’ as a means to understand the development of modes of activism 
that focus on knowledge production and knowledge mobilisation in the governance of health 
issues. We argue that such modes of activism are reconfiguring the role and dynamic of 
patients’ organisations, users’ and activists’ groups, and have broader consequences for the 
governance of the so-called ‘knowledge society’ in contemporary democracies. Before 
presenting our approach, we first contextualise our approach within the current research to 
delineate what exactly we mean by ‘evidence-based activism’. 
From ‘war on diseases’ to the dual shaping of conditions and health issues 
Amongst the transformations stated above, the involvement of patients’ organisations in 
biomedical research has been pinpointed as a watershed in health activism. Rich and detailed 
studies have documented the rationale that underlies this dynamic, and its consequences on 
the configuration and conduct of collective action associating patients and experts (Barbot 
2002; Dodier 2003; Brown et al. 2004; Epstein 1996; Novas 2006; Rabeharisoa & Callon 
1999; Rapp et al. 2001; Silverman 2011; Panofsky 2011; Stockdale 1997). 
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Firstly, these authors have stressed the emergence of new forms of activism in which 
patients’ organisations no longer confine their activities to the provision of help to their 
members and/or to advocacy for their rights and interests, but actively intervene in ‘war on 
diseases’ with an aim at finding a cure. ‘War on diseases’ has clustered around life-
threatening conditions such as cancers, rare genetic diseases and HIV/AIDS, to cite but a few, 
for which there has been no treatment, a situation that patients and activists have related to the 
lack of investments and/or focus in biological, clinical and therapeutic research. Patients’ 
organisations have thus mobilised to intervene in biomedical activities with a view to 
launching and accelerating the ‘quest for a cure’. In his pioneering work on Act-Up, Epstein 
(1995) coined the term ‘treatment activism’ to feature activists’ concern with the fight against 
the disease. In their study of the AFM
1
, Rabeharisoa & Callon (1999; Rabeharisoa 2006) 
pointed to the organisation’s shifting interests from directly helping patients and their families 
to manage illness towards being involved in research and clinical efforts to combat the 
disease, a detour that the AFM considered as a relevant and promising avenue for securing a 
better future for people suffering from myopathies. In contrast to previous patients’ 
organisations, which formed around chronic diseases and were mainly preoccupied with 
helping patients to cope with their illness experience (Pierret 2003) and manage their illness 
trajectories (Corbin & Strauss 1988), Act-Up, the AFM, and similar organisations, targeted 
diseases themselves as the focus of their mobilisation.  
Secondly, patients’ organisations’ concerns with disease and its exploration has entailed 
a redistribution of competencies and prerogatives between patients and credentialed experts. 
Certain patients and activists acquired scientific and medical knowledge, becoming what 
Epstein (1995) labelled ‘lay experts’, i.e. credible interlocutors of specialists. Patients’ 
organisations also collected, formalised and circulated patients’ experience as a legitimate 
body of ‘experiential knowledge’ (Arskey 1994; Borkman 1976) on their conditions, and 
became what Rabeharisoa & Callon (2004) called ‘experts of experience’. This two-fold role 
played by patients’ organisations, as ‘lay experts’ and ‘experts of experience’, has led to new 
forms of cooperation between patients and specialists in the production, discussion and 
dissemination of knowledge. This transformation extended the repertoire of styles of 
mobilisation enacted by patients’ and users’ organisations, adding to forms of contestation 
new modalities of articulation that bring together these organisations and specialists to 
negotiate the scope of epistemic arenas for their conditions. 
                                                 
1Association française contre les myopathies – French association against myopathies.  
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Thirdly, studies of patients’ organisations’ engagement in biomedical research have 
revealed the evolving nature of patienthood (Landzelius 2006). It is argued that not only 
patients cease to be passive and take an active part in the understanding of their conditions 
(Barbot 2006), but also that this involvement requires engagement with their self-description. 
Rabeharisoa & Callon (2004), in the case of myopathies, noted how some families (and 
doctors alike) who formerly saw their affected relatives as ‘defects of Nature’, progressively 
considered them as full-fledged human beings suffering from genuine diseases, who deserved 
to be recognised and treated as such. Patients’ organisations’ contribution to the production of 
knowledge both transforms the epistemic nature of their condition and raises the social status 
of affected people. This sometimes results in a new form of social relations between patients, 
which Rabinow (1999) has labelled ‘biosociality’ to indicate their condition-focused, 
knowledge laden and transformative power, which can however extends across disease areas 
in manifestations of solidarity through public donations to research on a range of ‘high 
profile’ diseases. These transformations of patienthood also brought tensions into 
organisations and movements. Epstein (1995), for example, showed how certain activists’ 
proactive encounter with researchers ended up in a schism between ‘lay experts’ and ‘lay lay’ 
patients within Act-Up, the latter arguing that the former eventually lose sight of ‘grass roots’ 
problems. 
The modalities of engagement are underpinned by reflexive work which echoes, as 
much as partakes, a number of aspects in the dynamic of contemporary health and medicine. 
It sheds light on the uncertainty and fragmentation of biomedical knowledge (Berg & Mol 
1998), which is particularly salient in contested condition-areas such as emergent 
environmental illnesses (Brown et al. 2004), or complex multi-factorial conditions like 
Attention Deficit Hyperactivity Disorder (ADHD), which is the focus of one chapter of this 
special issue. It also relates to the development of EBM that emphasises the importance of 
standards in guiding clinical work, leading to the transition from the ‘clinical tradition’ to 
what Dodier (2003) calls  ‘therapeutic modernity’. Thus, Cambrosio et al. (2006) have 
suggested that EBM standards are linked to the emergence of a distinctive type of objectivity, 
‘regulatory objectivity’, that focuses on the establishment of conventions through collectively 
concerted programmes of action, where patients and users play an increasing role. Drawing 
on Light’s theory of countervailing powers (Light 1991), Timmermans & Berg (2003) 
proposed that assessments of clinical effectiveness are part and parcel of a redistribution of 
accountability within health care systems where third parties attempt to gain access to the 
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‘black box’ of clinical judgment. In sum, one of the key characteristic of this dynamic in the 
field of health care is that knowledge – and the collective negotiation of what counts as such – 
has become central to the governance of health care services, programmes and systems. This 
further supports patients’ organisations, users’ and activists’ groups’ contribution to the 
evaluation of the ‘evidence-base’ of collective decision-making in the shaping of health care 
services and health research policies (Moreira, 2010; see also the chapter on Alzheimer’s 
disease in this issue). Patients’ organisations’ engagement in biomedical research thus offer a 
particularly interesting locus for social scientists to study lay people and their representatives’ 
contribution to the fabric of ‘knowledge society’, and lay people’ involvement in techno-
sciences as a crucial issue for democratising democracy (Callon et al. 2009). Patients’ 
organisations, users’ and activists’ groups have become key actors in this reflexive work by 
staging, weighting up, sorting, assessing, and reordering heterogeneous sets of information 
and data on their conditions and health problems they are concerned with. 
If a number of studies have focused on how and to what extent patients’ organisations, 
users’ and activists’ groups intervene into the fabrics and monitoring of health policies, few of 
them however have investigated the epistemic activities that these organisations and groups 
deploy to contribute to significant changes in issues at stake. Studies are mainly preoccupied 
with the representativeness of these organisations and groups, as well as their lobbying power 
vis-à-vis institutions. Baggott et al.’s (2004) research work on various health consumer groups 
in UK stands as one exception through their focus on how these groups’ expertise endows 
them with political legitimacy and power to influence institutional change. We take this a step 
further and examine how patients’ organisations, users’ and activists’ groups produce and 
mobilise evidence for transforming health issues and in so doing contribute to their 
governance. 
We propose the term ‘evidence-based activism’ to capture the variety of patients’ 
organisations, users’ and activists’ groups forms of engagement with knowledge. This means 
that rather than focusing only on patient organisations' interventions in biomedical research – 
as significant as this might be – we open the focus to a broader spectrum of knowledge-
related activities. In this, the term also aims at drawing attention to the multiplicity of forms 
of knowledge that these organisations and groups are mobilising, which includes biomedical 
knowledge but also health technology assessment, public health research or forms of judicial 
expertise. Most importantly, we coin the term ‘evidence-based activism’ to explore what we 
consider as an important shift in patient and health activism. We argue that ‘the quest for 
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cure’ is no longer the exclusive motive that drives patients and activists to engage with 
knowledge. Many patients’ organisations, users’ and activists’ groups are striving to raise 
public health issues that they deem relevant and significant for those affected in the way they 
feel appropriate. Because of the interlocking of knowledge governance and heath care 
organisation, knowledge is no longer a mere resource for grounding political claims; it is the 
very target of activism, in a process through which patient organisations' causes and political 
identity have to be continuously re-though and re-worked. We expand on this form of 
activism in the next section. 
What is ‘evidence-based activism’ about? 
In order to grasp the scope of the concept we are proposing, it is perhaps worth 
clarifying the use of key terms that underpin it. Drawing on our empirical observations, we 
use the term knowledge, be it credentialed knowledge or ‘experiential knowledge’, to 
designate statements on the nature of patients’ and activists’ conditions or situations. As 
mentioned above, these statements may be multiple, and even contradictory. ADHD for 
instance is conceived as a ‘brain disease’ by certain neurologists, a ‘behavioural disorder’ by 
certain psychiatrists, and a complex and multidimensional condition by parents of children 
who have ADHD. Expertise is the capacity of an individual or a group to produce 
propositions on whatever concerns the nature of the health issues at stake and on the way they 
should be dealt with. Those propositions are usually endowed with a degree of credibility 
underpinned by the recognised mastery of specific form of knowledge. Evidence results from 
the selection and articulation of knowledge statements in order to produce forms of expertise: 
it aims at providing robust knowledge on how patients’ and activists’ conditions or situations 
ought to be understood and treated. Evidence thus is a mediating tool between knowledge and 
expertise. The notion of ‘evidence-based activism’ allows to highlight first, the articulation 
between knowledge and politics which is central in this form of activism and second, the 
work which is necessary to perform this articulation. 
Evidence-based activism as a form of activism can be conceived through the following 
conceptual model: 
1. Patients’ organisations which engage in evidence-based activism collect 
experiences and build experiential knowledge, and that is how they give 
shape to concerned groups and delineate their preoccupations; 
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2. They articulate credentialed knowledge with experiential knowledge in 
order to make the latter politically relevant, e.g. to capture other 
stakeholders’ interests and raise health issues; 
3. Through this process, they usually reframe what is at stake, destabilising 
existing understandings of conditions and problems and resulting in the 
identification of zones of ‘undone science’ (Hess 2009; Frickel et al. 2010), 
thus inextricably linking patients’ organisations’ involvement in politics of 
health to politics of knowledge; 
4. The causes defended by patients’ organisations, the definition of their 
conditions, and the identities of concerned people are the outcomes of 
these knowledge-related activities rather than their causes; 
5. To achieve these epistemic shifts, patients’ organisations make themselves 
part and parcel of networks of expertise with credentialed experts and 
collaborate to some extent with health authorities as well as medical 
professionals, This leads them to adopt a ‘reformist’ rather than a purely 
confrontational perspective. 
We expand on the components of this model in the next sections. 
Shaping concerned groups and delineating their concerns 
Health professionals, political philosophers, and social scientists (Schicktanz 2012; 
Epstein 2007; 2011) have rightly pointed to the issue of representation: who are patients’ 
organisations representing? What allows them to speak on behalf of the people they claim to 
speak for? The patients’ organisations whose activism we describe here take these questions 
seriously by making them key components of their work of collecting experiences, opinions 
and suggestions from concerned people, be they members of their organisations or not. 
They do this through rather straightforward means, such as the collection and analysis 
of data reported in the subscription form to their organisations, or the collection of stories 
gleaned in support activities (help lines, internet forums, speech groups); in addition, they also 
engage in a rather sophisticated work, as is described in the chapter on Alzheimer’s Disease 
(AD). In Ireland as well as in UK, AD societies mobilised social research methods – and even 
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innovated in this matter – in order to represent the needs of the various people involved in AD 
care, informal as well as formal carers and the people with AD themselves, the latter posing a 
clear epistemic challenge to the researchers. It has resulted into various reports and position 
papers that propose a hybridisation of the kind of evidence that are taken into account in 
dementia care policy. This hybrid format is widespread characteristic of the experiential 
expertise produced by patients’ organisations, and can, we suggest, be understood as the 
expression of their mediating role between concerned people and health care system, or of 
their dual involvement in support as well as in advocacy activities. 
This work undertaken by patients’ organisations, which can be considered as partaking 
to the development of ‘technologies of democracy’ (Laurent, 2011), plays an important role in 
opening the route to the policy-making table, especially but not exclusively in countries where 
the participation of patients, users, and consumers to the governance of health issues has not 
been much institutionalised. Thus, despite their lack of recognition by the Health Ministry, the 
Association for the Improvement of Maternity Services in Ireland (AIMSI) was able to bring 
to bear issues of maternity care by drawing on surveys of women’s experiences of childbirth 
services. 
By producing evidence on people’s concerns in relation to their experiences of their 
conditions, patients’ organisations achieve two goals at once: they gather and constitute an 
assembly of ‘represented’ people by giving them a voice through the mediation of tools they 
use to collect and analyse their experiences; at the same time, they legitimise themselves as 
representatives of these people while eliciting the emergence of health issues that they bring 
to the attention of other stakeholders. 
Articulating experiential and credentialed knowledge and involving stakeholders 
To gain the attention of other stakeholders in their condition areas, patients’ 
organisations not only document patients’ singular preoccupations: they have to convince 
other stakeholders that they too are actually concerned. For this to be achieved, they try to 
link patients’ problems to the network of issues in which these stakeholders are already 
caught. Patients’ organisations thus devote a large amount of energy in articulating 
credentialed knowledge and ‘experiential knowledge’.  
Patients and activists do not simply align or oppose either of these two sorts of 
knowledge to each other. Instead, they are engaged in collecting and confronting them as a 
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key part of their activities. In connecting these two bodies of knowledge, patients’ 
organisations are translating people’s experience into the language of science and medicine 
and vice-versa, with an aim at rendering their situations perceptible not only to medical 
experts and health professionals but also to themselves. In doing so, patients’ organisations 
progressively constitute a seamless web of pieces of credentialed knowledge and ‘experiential 
knowledge’ that crafts their focus of activity. For example, it was through a careful analysis 
of the clinical effectiveness – which is supposed to underlie professional’s concerns – of 
procedures such as episiotomy or fundal pressure
2
 that childbirth activists’ groups managed to 
make room for women’s experiences, drawn on surveys they conducted. They succeeded to 
the point that recommendations for clinical practices now clearly pose limits to the use of 
these medical interventions. Thus, patients’ organisations, users’ and activists’ groups’ 
reflection on what counts as relevant knowledge plays a significant role in managing 
accountability and regulating processes in health care. 
In many instances, they also bring in bodies of knowledge which medical experts do not 
consider as central. This is notably the case when patients’ organisations, users’ and activists’ 
groups’ contemplate unsettled conditions such as ADHD and other similar ‘illnesses you have 
to fight to get’ as Dumit (2006) nicely puts it. In these situations, ‘stating the fact of the 
condition’ is a ‘matter of concern’ for those afflicted: connecting patients’ experiences to a 
wide range of medical, paramedical and non medical knowledge entails the building of a large 
multidisciplinary community invested in the understanding of the condition. In the case of 
ADHD for example, the epistemic eclecticism of the French group of parents aims at 
asserting a definition of the disorder and its treatments which encompasses all aspects of 
parents’ and patients’ experiences, and which counteracts professionals’ tendency to reduce 
the disorder to their specific domains of competencies.  
However, patients’ and activists’ interest in knowledge is not restricted to these sorts of 
condition-areas, as uncertainty bears on the negotiation of how to articulate knowledge 
making and political cause. This means that even for certain diseases whose scientific and 
medical understanding is, at least temporarily, quite stabilised, patients’ organisations, users’ 
and activists’ groups may raise health issues that they feel should be addressed, both at an 
individual and a collective level for the benefits of concerned people. Take Alzheimer’s 
disease, for example. There exists today a quite consensual scientific and medical definition 
                                                 
2 An incision of the perineum and the posterior vaginal wall during labour. 
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of AD as a neurodegenerative disease that impacts on fundamental cognitive functions and 
comes with severe impairments and disabilities. Although certain areas are still controversial, 
such as the genetic cause of early onset AD or the mechanisms which underlie the 
development of AD compared to other dementia and ‘normal’ ageing, AD is very much put 
under the jurisdiction of neurosciences which are agreed upon as the main relevant body of 
knowledge on this condition. This does not prevent patients’ and carers’ groups to raise the 
issue of care, and notably to question the relevance and effectiveness of standard clinical 
guidelines versus person-centred care: to do so, they mobilise bodies of knowledge – notably 
from social sciences – different from the one which is considered as relevant from a medical 
point of view. 
Thus, patients’ organisations’ expertise does not simply consist of juxtaposing 
experiential expertise and ‘lay’ expertise on formalised knowledge. Drawing on patients’ 
organisations’ reflexive analysis of their own activities, we suggest that, at least in the case of 
evidence-based activism, their expertise lies in their capacity to articulate various 
knowledges, so much so that what constitutes evidence for patients may also count as such for 
scientific and health professionals. As one member of the Alzheimer’s disease Society in UK 
declared about their expertise: ‘It brings together the expertise of carers with the skills and 
insights of health and social care professionals and the discoveries of scientific research.’3 
Conversely, patients’ organisations also develop a micro-politics of knowledge, through 
significant efforts to provide patients and their relatives with information about how to 
navigate within research and health care institutions and negotiate the management of their 
case with professionals. This implies translating scientific data into plain language, providing 
concerned people with background knowledge that support statements and claims, and 
producing ‘evidence’ that can be deployed in interaction with their various interlocutors. Rare 
diseases patients’ organisations, for example, equip their members with various knowledge-
based tools for them to be able not only to manage their conditions, but also to raise issues of 
organisation and provision of diagnosis, medical and social care. A similar effort has been 
deployed by Alzheimer's disease organisations, where information sheets have been produced 
to compile information on issues from coping with memory loss to statutory rights of people 
with dementia in their relationship with health care services.  
                                                 
3 Cayton, H. ‘Executive Director’s Message’, ADS newsletter, August 1996: p. 2. 
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Linking politics of knowledge to politics of health 
In the preceding section, we have described how POs articulate experiential knowledge 
and credentialed knowledge to mobilise a number of actors on issues primarily raised by 
patients. This work of ‘intéressement’ (Callon 1986) helps patients’ organisations to extend 
the list of actors and issues to be discussed, thus creating a collective space of debate. 
However, our suggestion is that this process goes even further, for it destabilises and 
questions both existing bodies of knowledge and care organisations. As suggested by above-
mentioned examples, patients’ organisations’ politics of knowledge is de facto a politics of 
healthcare. By bringing in new issues, patients’ organisations reframe what is at stake and 
redefine the list of entities – organisations, biological processes, interventions, etc. – that 
should be taken into account. Not surprisingly, this may lead them to identify zones of 
‘undone science’ (Hess 2009; Frickel et al. 2010), and/or of ignorance that should be 
investigated in order to bring to bear previously excluded issues.  
Zones of ‘undone science’ may concern a variety of questions such as the prevalence of 
diseases, an issue that patients’ groups on AD and ADHD have tackled by commissioning or 
being associated to research; the costs associated to various organisations of care for 
individuals as well as for communities and the State, an issue on which the Alzheimer Society 
of Ireland commissioned health economists to produce policy papers; medical practices which 
obstetricians consider as routines not even worth being discussed, while having important, 
and sometimes damaging effects from the perspective of women. Identifying zones of 
‘undone science’ may also lead to the opening of new complex scientific questions, as in the 
cases of some rare diseases we study in one chapter of this volume. In that case, the evidence 
brought to the table by a French group of families concerned with 22q11 deletion syndrome  
led to the investigation of the links between this syndrome and some psychiatric disorders,  
potentially redefining both the syndrome, its prevalence rate and its relation to psychiatric 
disorders. Similarly, the French childbirth organisation we studied put forward a hypothetical 
link between the use of oxytocyn during the second stage of labour and the occurrence of post 
partum haemorrhage, and pushed to the setting up of a research program which eventually 
confirmed this hypothesis.  
In this, as we have been arguing, knowledge is not only a mere resource that patients’ 
organisations, users’ and activists’ groups carve out for promoting institutional changes. 
Through their engagement with knowledge, patients’ organisations are able transform the 
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very definition of conditions and of issues at stake, both at and individual and a collective 
level. We should stress however that our contention is that knowledge is not only part and 
parcel of today’ s politics; political action is also a mean through which epistemic changes, as 
well as new knowledge making procedures and institutions are promoted. Again, in the area 
of rare diseases, interlinked platforms (Keating & Cambrosio 2003) for research and clinical 
activities, associating medical and health institutions, patients’ organisations, industry and 
regulatory bodies, stand as new institutional configurations which sustain significant changes 
in the production of knowledge on these conditions and in the nature of what counts as 
relevant knowledge. 
Redefining conditions, causes and identities 
Such characterisation of patients’ organisations’ activities needs further 
contextualisation. The patients’ organisations we studied belong to what Allsop et al. (2004) 
identified as ‘condition-based groups’, or at least ‘experience-based’ in the sense that they 
gather people sharing similar personal experiences in which medicine plays a significant role 
as is the case of pregnancy and childbirth. They neither belong to health access movements 
nor to constituency-based movements as described by Brown & al. (2004), i.e. they are not 
primarily defined by a political orientation, such as the defence of rights, access to care, or the 
fight against discrimination based on race, class, gender, ethnicity, sexual orientation etc. 
even if, at some point, they can take on board such a problematisation. They are interested in 
making sense of their experience and improving their life, in questioning the role of medicine 
and medical knowledge alongside other fields of expertise, and in elaborating concrete 
answers to issues related to their conditions. To some extent, they share a number of 
characteristics with Embodied Health Movements as conceptualised by Brown and colleagues 
(2004). However, as we already mentioned, the notion of ‘evidence-based activism’ entails a 
wide range of knowledge-based activities. More importantly, it places knowledge-related 
activities at the heart of patients’ organisations functioning: indeed, their engagement in 
knowledge-related activities can be understood as a multidimensional exploration of their 
conditions, whose definition is at stake over this process, and whose political implications 
proceed from this process rather than the other way round. 
This is especially striking in the case of childbirth activism which has often been 
studied as belonging to a wider feminist movement.  The close examination of their current 
functioning presented in one of the chapters of this issue reveals that they are not driven by 
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pre-existing ‘ideological’ slogans. In the case of the Irish childbirth organisation for instance, 
the absence of a shared ‘ideology’ amongst volunteers, as well as the lack of an institutional 
demand for representation, created space for a politics of representation drawn intensively on 
the analysis of their surveys on women’s experiences, tackling issues such as what matters to 
women (availability of information and consent, or pregnancy loss). In other cases, where 
activists’ groups are urged to participate to the governance of health but do not fully control 
the agenda setting, we observed that the collective exploration in which they participate leads 
them to progressively reframe their objectives and claims. This is the case with the British 
elaboration of a consensus statement on ‘normal birth’. Starting from a ‘radical’ perspective 
on ‘normal birth’ which excluded any medical intervention, activists’ groups engaged into a 
collection of data in order to evaluate the occurrence of such non medicalised birth practices, 
which led them to progressively forge a slightly more flexible notion of ‘normal birth’ that 
would be workable, measurable and acceptable by professionals. In this process, their politics 
of childbirth came to be transformed A similar dynamic is observable in the case of 
Alzheimer's disease, where knowledge work to make the person living with dementia the 
focus of therapeutic evaluation and quality of life research in turn entailed a complicated and 
sometimes conflicting hybridisation of the constituency the movement is supposed to 
represent (O'Donovan, Moreira & Howlett 2013).  
As ‘evidence-based activism’ also targets the definition of the condition itself, it is no 
surprise that health issues and the possible collective identity to which it relates might also be 
affected. Through ‘evidence-based activism’, patients’ organisations explore concerned 
people’s singular experiences and specific issues that echo their preoccupations. This involves 
back and forth movements between their members’ situations and knowledge on seemingly 
comparable conditions. The chapter on rare diseases explicitly addresses this process of 
‘singularisation’, and shows how patients’ organisations’ engagement in research 
encapsulates their reflexive work on the very notion of ‘rareness’ and on the relevant 
similarities and differences between their conditions and problems they encounter in regard to 
‘non-rare’ diseases. Through this process of ‘singularisation’, patients’ organisations 
formulate and experiment a new sort of relation between the particular and the general nature 
of conditions and causes. Rather than positing the existence of general causes which stand 
above patients’ organisations’ particular concerns and around which they may want to 
coalesce in order to demand interventions at a collective level, we examine how their 
epistemic efforts lead them to dig around and relate their singular problems to equally 
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singular situations experienced by others. ‘Evidence-based activism’ thus helps to renew 
reflection on the fabrics of collectives and collective interests. In a similar vein, the chapter on 
Alzheimer’s disease offers a look at how standardised care and person-centred care both 
propose specific articulations between experiential and credentialed knowledge and expertise, 
and bring in different understandings of the process of singularisation versus the process of 
generalisation thereof (see also Moreira 2012).  
Our contention is that the study of this process of singularisation (in contrast to the 
process of generalisation) is a fruitful way for understanding why and how patients’ 
organisations, users’ and activists’ groups coalesce around (temporarily) related causes, and 
for gaining thick empirical and analytical insight into the dynamic of health activism. This, 
we hope, may help to open the ‘black box’ of health movements which are too often 
presented as de facto general new social movements in the domain of health and medicine. 
Partnering with health authorities and medical professionals 
Although our focus so far has been on patients’ organisations’ activities, it would be 
inaccurate to see patients’ organisations as isolated actors in their engagement in knowledge 
work. One aspect of ‘evidence-based activism’ that we address in this special issue is the 
variety of relationship that patients/users/activists establish with experts. Certain groups of 
patients and families concerned with rare diseases for instance develop full-blown 
collaboration with biologists, clinicians and industry, and contribute to the creation of 
communities of patients and specialists as actors in ‘war on diseases’; other groups step back 
from biomedicine and call for social and human sciences research to address disability issues 
that they consider as important bottlenecks for patients’ inclusion in society.  
Not only patients’ organisations, users’ and activists’ groups target different experts; 
they also adjust their encounter with these experts according to their priorities at certain 
moments in their history. In this respect, Blume’ s (2009) research work on deafness opened 
the way for a reflection on the variety of knowledge and credentialed experts that patients and 
activists ally with and/or oppose to. As he convincingly demonstrated, deaf communities’ 
opposition to the medical professionals did not mean a systematic and total rejection of all 
credentialed knowledge. Instead, this meant an alignment with sociolinguistic research to 
establish that sign language is a language in and of itself, and to enhance the social and 
political recognition of deaf people as merely 'different' and not ‘disabled’.  
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The proximity between experts and patients’ organisations which results in some 
instances from these collaborations may lead to a blurring in the ‘roles’ and positioning of the 
involved actors. In the case of ADHD, for instance, certain specialists who develop close 
relation with parents’ groups and who share with them the same understanding of the 
disorder, come to defend their cause as much as families do. From this perspective, the 
networks of expertise that patients’ organisations we studied form with credentialed experts 
share some features with what Haas (1992: 3) called ‘epistemic communities’, i.e. ‘a network 
of people with recognised expertise and competence in a particular domain and an 
authoritative claim to policy-relevant knowledge within that domain or issue-area.’ Patients’ 
organisations and experts they collaborate with participate to a joint epistemic and policy 
enterprise, through a collective investigation of the complex, multiple, and often uncertain 
links between knowledge, policy actions and their outcomes.  
Unlike 'embodied health movements' (Brown et al. 2004), which also ally with 
sympathetic researchers but are associated with a confrontational culture and a larger social 
movement challenging existing forms of authority and power, patients’ organisations which 
engage in ‘evidence-based activism’ do acknowledge the importance of scientific and medical 
collectives, but on the condition that they are considered as legitimate contributors to these 
collectives’ activities and policies. To put it differently, they partner with these collectives 
with an aim at influencing their activities and policies by introducing their experience and 
concerns. They do neither simply oppose these collectives, nor do they merely become 
‘insiders’; rather, they act as reformers, with the ultimate goal of shaping the rules of the 
game differently. 
This has consequences on the issue of medicalisation / demedicalisation. We argued 
above that patients’ organisations which engage in ‘evidence-based activism’ do not simply 
stand outside of the medical world in a contesting and claiming position; they collaborate to a 
certain extent and on certain conditions with health authorities as well as medical 
professionals. As a consequence, one can reasonably ask whether childbirth movements – 
which have long been described as movements seeking for demedicalisation of birth practices 
– still deserve this labelling. In light of what we observed in four countries, we argue that the 
‘evidence-based activism’ that these groups have embraced in the last years cannot be 
reduced to this problematic. Through the careful and expert analysis of medical literature and 
practices they develop, it becomes clear that what is at stake is much more a redefinition of 
obstetrics practices, with an aim at leaving room for women to take an active part in the 
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decision-making process. As such, childbirth movements are no longer simply opposing a 
naturalistic or humanistic definition of birth to a medical one, but are trying to build an 
approach which revisits and articulates these different aspects. 
A symmetrical analysis can be conducted on the issue of medicalisation. It has been 
argued (Barker 2005, 2011; Conrad 2007) that the emergence of a number of new pathologies 
such as ADHD or fibromyalgia corresponds to a reframing of social problems into medical 
ones. Forms of suffering that originate in poor conditions of life – whether they translate in 
disproportionate expectations on the individual performance, or in the incapacity of society to 
respond with humanity to the ‘normal’ dramas of existence – are put under the jurisdiction of 
medicine and transformed into treatable conditions. In this context, ‘evidence-based activism’ 
which articulates experiential knowledge to medical knowledge could be interpreted as 
enforcing this medicalisation trend, and depoliticising social problems thereof. The ADHD 
case suggests otherwise. Parents’ groups consider engaging with medical knowledge as a 
unique opportunity to get rid of the blame of bad parenting which, according to families, 
stigmatises them and offers nothing to solve the multiple problems encountered by the 
children and their parents, then to initiate a complete assessment of the child’s individual 
situation including all aspects of the trouble, and finally to elaborate a multimodal approach 
associating educational methods, psychotherapies, rehabilitation, medication and social care. 
For these parents’ groups, engaging with medical knowledge is conceived as a way for 
opening up an arena of negotiation with scientists, doctors, teachers and health professionals, 
and for scrutinising and ultimately acting upon social structures and processes which 
potentially lead to the exclusion of children with ADHD.   
Evidence-based activism’s conceptual ambitions 
In the sections above, we outlined the key components that make evidence-based 
activism a distinct and significant form of mobilisation in the domain of health and health 
care. We suggested that these components work together to produce a form of activism that 
targets both epistemic and political issues and which, in this process, often transforms the 
very spirit of the organisations that deploy it: their cause, their constituency, their modes of 
activism, etc. Our attention to the dynamics of this type of activism is not solely motivated by 
a descriptive ambition but also by a conceptual ambition to explore the relationship between 
health, medicine and health movements in contemporary technological democracies.  
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We propose that evidence-based activism should be conceived not merely as a type of 
mobilisation in the domain of health but as partaking in the transformation of relationships 
between actors, groups and institutions, by actively contributing to the growing 
interconnection between previously separated spaces. From this perspective, evidence-based 
activism is part and parcel of the contemporary organisation of health care as described by 
Clarke and colleagues (2009), contributing to the definition of medical practices, of medical 
research, and of care provision, by bringing to bear the figure of the patient. However, in so 
doing, they are confronted with the epistemic and political problems of representation that 
traverse contemporary biomedicine (Epstein 2007). This means that, in the process of 
producing knowledge on experiences and building a user’s expertise on care organisations 
and medical practices, patients’ organisations are also required to configure their members’ 
abilities, equipping patients with knowledge of research practices, medical procedures and 
organisational formats. The mediating role that patients’ organisations’ play between 
knowledgeable patients and specialists is both a requirement for their involvement in the 
collective production of evidence, and a threat to their claim to such participation, making 
them liable to accusations of bias or corporatisation.  
That evidence-based activism is not a confrontational form of mobilisation might sit 
uncomfortably with the focus of social movement scholarship in studying processes of 
conflict and contestation and its concern with progressive politics and social justice. Given 
evidence-based activism concern with knowledge, we find parallels between their strategies 
of reformist engagement and Stengers’ s (2005) conceptualisation of the ‘working with’ the 
sciences to provide an opening to their social and political environment. Avoiding usual 
critiques of social constructionist analysis of knowledge making that traverse much of the so-
called ‘science wars’, Stengers’ interest represents an attempt to work with the traditions of 
modern science to re-invent or re-imagine them ‘from within’. Again, there are risks 
associated with this strategy, as patients’ organisations might be seen to become incorporated 
in others’ agenda (Epstein, 2008). However, it is a consequence of having to articulate 
epistemic and political issues that patients’ organisations are rarely able to stabilise their 
causes and become fully integrated. In the case of evidence-based activism, uncertainty works 
against assimilation and pacification around issues. 
This propensity to generate political and knowledge uncertainties has effects on the way 
in which patients’ organisations relate to their publics and to each other. Through an 
interactive and iterative articulation of experiential knowledge and formalised knowledge, 
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patients’ organisations contribute to the reorganisation of disease entities, clinical 
relationships and patients’ identities. If, on the one hand, this mean they have to work hard at 
producing and maintaining the link between them and their members, it is also significant that 
this identity work becomes engulfed in fluid alliances with other patients’ organisations and 
associated networks. These processes, which rely on joint moves of singularisation and 
generalisation, make patients’ organisations and evidence based activism privileged places to 
observe the dynamics of contemporary biomedicine, as their constructing linkages between 
different conditions and issues impinges on the framing and re-framing of what partakes in 
health care.  
Another consequence of this is that it becomes difficult to ascertain boundaries of 
medicine and to study its expanding or diminishing remit. Rather than using a regional 
metaphor to describe how the emergence of medical categories comes to affect how persons 
interpret their situation and their relationship with others (Conrad 1992), we might instead 
want to draw on the image of the fluid (Mol & Law 1994) whereby a person, issue or object 
might be caught up in multiple, co-existing arrangements of the relationship between health, 
illness and politics. Again, evidence-based activism is a good site to investigate this 
multiplicity of biomedicine as patients’ organisations engage with multiple issues 
simultaneously as a matter of course in their activities (Dodier & Barbot 2006).   
About this issue 
This collection draws on a European research project called EPOKS (European 
Patients’ Organisations in Knowledge Society 4 ), whose objective was to study patients’ 
organisations, users’ and activists’ groups’ knowledge-related activities in four condition-
areas – rare diseases, Alzheimer’s disease, Attention Deficit Hyperactivity Disorder (ADHD), 
and childbirth –, and in four European countries – France, UK, Ireland and Portugal –. In 
addition, we studied European coalitions of patients’ organisations, users’ and activists’ 
groups in the above-mentioned condition-areas, and notably knowledge-related activities they 
conduct in collaboration with their national and local level member organisations.  
We chose the four condition-areas according to four criteria. Firstly, all four are 
considered as major public health issues in the four countries we examined. Secondly, all four 
                                                 
4 This project benefited from a three-year financial support (2009-2012) from the ‘Science in 
Society’ initiative of the European Commission FP7. 
http://www.csi.ensmp.fr/WebCSI/EPOKSWebSite/ 
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benefit from patients’ organisations, users’ and activists’ groups’ intense involvement in 
knowledge-related activities. Thirdly, we were sensitive to the variety of knowledge and 
expertise that these organisations and groups mobilise, and notably to the fact that not all of 
them align with biomedicine. Fourthly, not all of them are stabilised from a scientific and 
medical point of view: ADHD for instance is the object of fierce controversies amongst 
specialists, whereas a more consensual definition exists for Alzheimer’s disease. Our choice 
of childbirth warrants a specific mention here, for childbirth is not a condition per se. The 
reason why we included childbirth is two-fold: (i) childbirth, although considered as an 
intimate life event by activists’ groups, is nonetheless strongly embedded in the medical 
realm; (ii) childbirth offers an interesting locus for studying activists’ intervention in medical 
practices, and notably the critical appraisal of EBM that some activists’ groups put at the core 
of their action. 
Our approach was not to compare organisations and groups in light of the national 
contexts into which they evolve, nor did we compare them according to their organisational 
features. Although all those factors impinge on the politics of these organisations and groups, 
we approached them the other way around. We begun by identifying and analysing their 
modes of engagement with knowledge and the nature of evidence they mobilise, and then 
looked at how their epistemic activities transform the networks of expertise and issues to 
which they make themselves part and parcel of in their countries, as well as the content and 
scope of their activism. This approach stems from our hypothesis on the crucial role played by 
the epistemic work undertaken by these organisations and groups on their conditions and 
causes. This does not mean that we are not interested in similarities and differences between 
these organisations and groups, but that we consider these similarities and differences as the 
provisional outcomes of their reflexive work on their conditions and related issues. In 
addition, we observed that similarities and differences are also worked on by these 
organisations and groups through their alliances, notably within European coalitions, as well 
as through the circulation of experience and knowledge that they contribute to: quite 
pragmatically then, we looked at how these organisations and groups identify themselves vis-
à-vis each other (if they do).  
Our approach also consists of studying these organisations and groups as particularly 
interesting loci for addressing research questions on the role of knowledge in the shaping of 
political activities. We did not look at these organisations and groups for themselves, but for 
their contribution to collective actions that question the politics of health and the functioning 
 22 
of medical institutions. In doing so, we intend to take seriously into consideration the fact that 
these organisations and groups develop highly hybrid activities that cannot be simply be 
labelled advocacy or lobbying, opposition to, or alliance with institutions. Many scholars 
(Epstein 2008; Brown et al. 2004) rightly emphasise the hybrid or boundary nature of health 
activism and movements as one feature of contemporary patients’ organisations, users’ and 
activists’ groups. This prompted us to look at how these organisations’ and groups’ range of 
activities eventually change their public identification, and even for some of them, the 
boundaries of their membership. 
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